MDx Firms Get $9M in NCI Bridge Grants | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded nearly $9 million in new Small Business Innovation Research grants to the biomarker-based and molecular diagnostic cancer testing companies 20/20 GeneSystems, AmberGen, and Advanced Cell Diagnostics (ACD).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.